Rucaparib: An emerging parp inhibitor for treatment of recurrent ovarian cancer.
Musella A, Bardhi E, Marchetti C, Vertechy L, Santangelo G, Sassu C, Tomao F, Rech F, D'Amelio R, Monti M, Palaia I, Muzii L, Benedetti Panici P.
Musella A, et al. Among authors: vertechy l.
Cancer Treat Rev. 2018 May;66:7-14. doi: 10.1016/j.ctrv.2018.03.004. Epub 2018 Mar 23.
Cancer Treat Rev. 2018.
PMID: 29605737
Review.